R Haraden

Abbott (United States)

Papers

1

Total Citations

158

H-Index

1

About

R Haraden is a pivotal figure in the history of clinical diagnostics, best known for revolutionizing automated immunoassay testing. His primary research areas encompass clinical laboratory automation, immunochemistry, and assay technology development. Haraden’s most significant contribution is his leadership in the creation of the Abbott IMx, the first fully automated benchtop immunochemistry analyzer, which transformed hospital and reference labs by enabling rapid, high-volume testing. His seminal 1988 paper on the system, which has garnered 158 citations, introduced two groundbreaking technologies: the Microparticle capture Enzyme ImmunoAssay (MEIA) for large-molecule analytes and fluorescence polarization immunoassay. This work not only set a new industry standard for sensitivity and throughput but also laid the foundation for modern point-of-care diagnostics. Haraden’s innovations directly accelerated the adoption of automated immunoassays in clinical settings, impacting millions of patient tests worldwide. His legacy endures as a cornerstone of laboratory medicine, bridging engineering and clinical chemistry to make complex testing accessible and efficient.

Research Focus

Key Achievements

1
H-Index
1
Papers
158
Total Citations
158
Avg Citations/Paper
🏆 Most Cited Paper
The Abbott IMx automated benchtop immunochemistry analyzer system.
158 citations · 1988
📈 Most Prolific Year: 1988 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Abbott (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago